Valuation: ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 13.36B 2B 1.79B 1.64B 1.5B 2.82B 188B 2.91B 19.76B 7.88B 100B 7.51B 7.35B 317B P/E 2026 *
25.7x
P/E 2027 * -129x
Enterprise Value 13.36B 2B 1.79B 1.64B 1.5B 2.82B 188B 2.91B 19.76B 7.88B 100B 7.51B 7.35B 317B EV / Sales 2026 *
12.4x
EV / Sales 2027 * 10.6x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day-1.39%
1 week+5.16%
Current month+7.66%
1 month-10.49%
3 months-17.78%
6 months-28.15%
Current year-11.24%
1 week 27.41
Extreme 27.41
30.55
1 month 27.33
Extreme 27.33
33.64
Current year 27.33
Extreme 27.33
45.88
1 year 27.33
Extreme 27.33
56
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.577775
81.48
Manager TitleAgeSince
Chief Executive Officer 52 11/11/2015
Director of Finance/CFO 60 11/11/2015
Investor Relations Contact 38 31/12/2020
Director TitleAgeSince
Director/Board Member 70 01/07/2024
Chairman 52 11/11/2015
Director/Board Member 58 11/11/2015
Date Insider Type Main position Quantity % Market Cap. Importance
5/1/26 Buy

Director

4,200 0.0010%
24/11/25 Buy

Director

7,000 0.0017%
1/9/23 Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%+5.16%-40.59%+0.10% 2.03B
-0.27%-3.96%+45.23%+128.74% 1,216B
+0.94%+0.74%+47.19%+81.42% 656B
+0.80%-1.67%+32.38%+105.35% 509B
-0.36%-3.25%+47.17%+64.58% 384B
-0.21%-2.01%+70.81%+40.43% 362B
-0.78%-0.52%+30.57%+57.98% 311B
-0.80%-0.21%+8.54%+35.56% 293B
+0.27%-1.00%+46.19%+69.10% 249B
-0.07%-1.78%+35.86%+106.62% 208B
Average -0.29%+1.03%+32.33%+68.99% 418.98B
Weighted average by Cap. -0.08%+0.04%+42.26%+88.50%

Financials

2026 *2027 *
Net sales 1.08B 162M 145M 133M 121M 228M 15.2B 235M 1.6B 637M 8.11B 607M 594M 25.61B 1.26B 188M 169M 154M 141M 266M 17.71B 274M 1.86B 742M 9.45B 707M 692M 29.83B
Net income 526M 78.76M 70.64M 64.56M 58.93M 111M 7.4B 115M 778M 310M 3.95B 296M 289M 12.47B -102M -15.27M -13.7M -12.52M -11.43M -21.53M -1.44B -22.21M -151M -60.17M -766M -57.33M -56.1M -2.42B
Net Debt - -
Projected Income Statement - Annual - ApicHope Pharmaceutical Group Co., Ltd.
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
06/11/26 CNY 29.78 -1.39% 2,953,624
05/11/26 CNY 30.20 +2.30% 4,199,824
04/11/26 CNY 29.52 +4.61% 5,606,462
03/11/26 CNY 28.22 -0.60% 3,448,282
02/11/26 CNY 28.39 +2.64% 4,312,529

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - ApicHope Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 300723 Stock